| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
Barclays analyst Adam Seiden maintains Arcosa (NYSE:ACA) with a Overweight and raises the price target from $106 to $115.
Arcosa (NYSE:ACA) narrows FY2025 sales outlook from $2.850 billion-$2.950 billion to $2.860 billion-$2.910 billion vs $2.869 bi...
Arcosa (NYSE:ACA) reported quarterly earnings of $1.56 per share which beat the analyst consensus estimate of $1.34 by 16.77 pe...
Arcosa, Inc. (NYSE:ACA), a provider of infrastructure-related products and solutions, announced today the dual listing of its c...
DA Davidson analyst Brent Thielman maintains Arcosa (NYSE:ACA) with a Buy and raises the price target from $110 to $120.